-
- 2B4
- 2-HG
- 5-Hydroxytryptamine (5-HT) receptor 2A (HTR2A)
- 6-[18F]-fluoro-3,4-dihydroxy-L-phenylalanine ([18F]FDOPA)
- +7/−10
- +7/-10 chromosome copy number changes
- ACE
- Activin A
- ACTN4
- ACVR1
- Adenylate cyclase 2 (ADCY2)
- AKIP1
- AKT1
- ALDH3A1
- Aliphatic amino acids (valine, leucine, isoleucine)
- ALK
- Angiogenin
- Angiopoietin 1
- Angiopoietin 2
- Annexin A2
- Antigen Processing and Presentation (APP)
- ANXA3
- ANXA7
- APC
- APOC1
- ARG1
- ARPC1B
- ASS1
- ATIIR1
- ATM kinase
- ATRX
- ATRX (Alpha thalassemia/mental retardation syndrome X-linked gene)
- B2M
- B7-H3
- B7-H3 (CD276)
- BAX
- B cell biomarkers (CD19 and CD79A)
- Bcl-3
- BCL3 (B-cell CLL/lymphoma 3)
- BCL7A
- Bevacizumab (BVZ)
- Bmi1
- BMI1
- B-Raf
- BRAF
- BRAFnon-V600E
- BRAF V600E
- BRAFV600E
- BRAF V600E mutation
- BRAF(V600)-Mutant Gliomas
- BTLA
- C1RL (Complement C1q Receptor-Like)
- Carbonic anhydrase 9 (CA9)
- Carbonic anhydrase IX (CA IX)
- Carmustine
- Carmustine wafer implants
- Cathepsin B
- Cathepsin D
- CBD
- CCL2
- CCL3
- CD10
- CD105
- CD11b
- CD123
- CD127
- CD133
- CD133/CD44
- CD134
- CD137
- CD137L
- CD138
- CD14
- CD146
- CD15
- CD152
- CD152L
- CD154
- CD155
- CD16+
- CD16−
- CD163
- CD19
- CD2
- CD20
- CD206
- CD209
- CD226
- CD24
- CD25
- CD253
- CD253L
- CD27
- CD273
- CD274
- CD276
- CD278
- CD278L
- CD279
- CD28
- CD282
- CD28L
- CD3
- CD3+
- CD300e
- CD31
- CD33
- CD34
- CD366
- CD39
- CD4
- CD40
- CD40L
- CD44
- CD45
- CD45RO
- CD47
- CD48
- CD4+ immune cell biomarker (CD4)
- CD56
- CD59
- CD66b
- CD68
- CD70
- CD73
- CD8
- CD8+
- CD80
- CD80L
- CD83
- CD83L
- CD86
- CD86L
- CD8A
- CD94/NKG2A
- CD96
- CDH1
- CDK4
- CDK6
- CDKN1A
- CDKN2A
- CDKN2A/2B
- CDKN2A/B
- CDKN2B
- CHD5
- Cholecystokinin receptors (CCKR)
- Choline (Cho)
- CLIC1
- c-Met
- COL1A1
- COL1A2
- COL5A1
- Creatine (Cr)
- CREBBP
- CRIP2
- CSF1
- CSTA (Cystatin A)
- CTLA-4
- CTNNB1
- CXCL12β (C-X-C motif chemokine ligand 12β)
- CXCR1
- CXCR4
- CXCR4 (C-X-C motif chemokine receptor 4)
- Delta-24-E1A
- Dendritic cell biomarkers (HLA-DPB1, HLA-DQB1, HLA-DRA, HLA-DPA1, CD1C, NRP1, and ITGAX)
- DGKI Methylation Status
- DLL4
- DNA mismatch repair deficiency
- E1A
- E2F
- E2F transcription factors
- E-cadherin
- EGFR
- EGFR amplification
- EGFR amplification and rearr
- EGFR amplification and rearrangement
- EGFR (epidermal growth factor receptor)
- EGFR (Epidermal Growth Factor Receptor)
- EGFR gene amplification
- EGFR overexpression
- EGFR type III mutant
- EGFRvIII
- EGR4
- Endostatin
- Endothelin 1
- EpCAM
- EphA2
- Epidermal Growth Factor Receptor
- Epigenetic targets (DNA methylation, chromatin modeling, and histone modifications signaling)
- ERBB2
- ERK-RAS-RAF mitogen-activated protein kinase pathway (BRAF mutation)
- EZH2
- EZHIP
- FABP5 (Fatty Acid Binding Protein 5)
- FALSG
- FANCA
- FAP (Fibroblast activation protein-α)
- FasL
- FBP1
- FBXW7
- FGFR3
- FGFR3-TACC3
- FGFR3-TACC3 fusion
- Fibroblast activation protein (FAP)
- Fibroblast Activation Protein (FAP)
- Fibronectin 1 (FN1)
- Fms related receptor tyrosine kinase 1 (FLT1, VEGF receptor 1)
- FN1
- Forkhead box M1 (FOXM1)
- FOXG1
- FOXM1
- FOXP3
- Gastrin-releasing peptide receptors (GRPR)
- GD2
- GD2 pathway
- GFAP
- GFAP (glial fibrillary acidic protein)
- Glial fibrillary acidic protein (GFAP)
- Glial Fibrillary Acidic Protein (GFAP)
- Glioma stem cell (GSC) markers
- Glucagon-like peptide 1 (GLP-1) receptors
- GLUT1
- GLUT1 (glucose transporter 1)
- GLUT3
- Glutamate carboxypeptidase II (Prostate-Specific Membrane Antigen)
- Glutamate (Glx)
- Glutamine (Gln)
- Glycine (Gly)
- gp96 (glucose-regulated protein 96)
- GPR77
- GSK3β
- H3 G34
- H3 K27M
- H3-wildtype
- HER2
- HER2 (human epidermal growth factor receptor 2)
- HES1
- HEY1
- HGF
- HGF/SF
- HIF1A
- High microsatellite instability
- High tumor mutational burden
- Histone H3.3 K27M mutation
- HK2
- HLA-A/B/C
- HLA-DRA
- HLA-E
- HLA-G
- HLA-I
- Homeobox Protein C9 (HOXC9)
- HOTAIR
- HOXA5
- HOXD4
- HSF1
- HSP90 (heat shock protein 90)
- HSPA5
- HVEM
- Hypoxia-inducible factor-1 alpha (HIF-1α)
- ICOS
- IDH1
- IDH1/2
- IDH1/2 (Isocit
- IDH1/2 (Isocitrate dehydrogenase genes 1 and 2)
- IDH1 and IDH2
- IDH1 G105G SNP
- IDH1-Mutant Solid Tumors
- IDH1 R132H
- IDH2
- IDH (isocitrate dehydrogenase)
- IDH-mutant tumor cells
- IDH mutations
- IDH-wildtype
- IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
- IDO
- IDO-1
- IGF-1
- IGF-2
- IGF2R
- IGF-binding protein 2 (IGFBP2)
- IGFBP2
- IGFBP5
- IGF-receptor
- IKK
- IKKα
- IKKβ
- IKKγ
- IL-10
- IL10
- IL-13Ra2
- IL13RA2
- IL13Rα2
- IL8
- Immunosuppressive Genes
- Integrin αvβ3
- Interleukin 8 (IL8)
- IPH2101
- IPH2201
- IRF8
- Isocitrate dehydrogenase 1 and 2 (IDH1/2)
- Isocitrate dehydrogenase (IDH)
- ITGB2
- IκBɛ
- IκBα
- IκBβ
- JARID 1B
- Ki-67
- Ki67
- KIF20A
- KIRs (Killer inhibitory receptors)
- KIT
- Klf4
- LAG-3
- LAG3
- LAMB1
- LAMC1
- LANCL2 (Lanthionine Synthetase C-Like 2)
- LDH-A
- LDL Receptor
- LGALS1
- LIF
- Lipid + lactate
- lirilumab
- LITAF
- Lomustine
- LRRC3
- M1 macrophage biomarkers (IRF5 and PTGS2)
- M2 macrophage biomarkers (CD163, VSIG4, and MS4A4A)
- MALAT1
- MARCO
- Matrix metallopeptidase 8 (MMP8)
- MCT-1
- MDM2
- MDM4
- MEG3
- MEK/ERK
- Melanocortin 1 (MC1) receptors
- MET
- Metabotropic glutamate receptor 1 (GRM1)
- Methylation of MGMT promoter
- MGMT
- MGMT (O(6)-Methylguanine-DNA Methyltransferase)
- MGMTp
- MGMT promoter methylation
- MHC class I
- MICA
- MICB
- miR-10b
- miR-21
- MIR34AHG
- MLH1
- MMP2
- MMP9
- MSH2
- MSH6
- MTAP
- MTHFR rs1
- MTHFR rs1801133 Polymorphism
- mTORSer2448
- MYC
- MYCN
- Myoinositol (mI)
- N-acetylaspartate (NAA)
- Nanog
- N-cadherin
- NEAT1
- Nestin
- Neural stem cell (NSC) markers
- Neurokinin 1 (NK1) receptors
- Neuroligin-3 (NLGN3)
- Neuron-specific enolase (NSE)
- Neurotensin (NT) receptors
- Neutrophil biomarker (ITGAM)
- NF1
- NFE2L2
- NF-κB
- NIK
- NKG2A
- NKG2D
- NOD2
- Notch
- Notch 1
- NOTCH1
- Notch 4
- NRP1
- NTRK
- NTRK1
- NTRK family
- NUSAP1
- O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET)
- O6-Methylguanine–DNA Methyltransferase
- O-6-methylguanine-DNA methyltransferase (MGMT)
- O6-methylguanine-DNA-methyltransferase (MGMT)
- OAS1
- Oct4
- OCT4
- Olig-2
- OLIG2
- Oligodendrocyte lineage genes (OLIG)
- Oligodendrocyte precursor cell (OPC) markers
- OX40
- P100
- P105
- p21
- p-38α
- P50
- P52
- p53
- P53
- P65
- P-AKT
- PAPPA
- PARP-1
- PBK
- PD-1
- PD1 (PDCD1)
- PD1/PD-L1
- PD-1/PD-L1 pathway
- PDGF
- PDGFR
- PDGFRA
- PDH
- PDK1
- PD-L1
- PD-L1 (programmed cell death ligand 1)
- PD-L2
- PD-L2 (programmed cell death ligand 2)
- P-ERK
- PI3K/AKT
- PIK3CA
- PKM2
- Platelet-derived growth factor (PDGF)
- Platelet-Derived Growth Factor Receptor Alpha
- PLEKHG5
- PMS2
- Poly(ADP-ribose) polymerase (PARP)
- PRAME
- Prostate-specific membrane antigen (PSMA)
- Protein kinase D1 (PRKD1)
- PRR
- P-STAT3
- PTEN
- PTPN11
- PTPRJ
- PTPRZ1
- PTPRZ1-AFAP1L2/XB130
- PTPRZ1-Akt
- PTPRZ1-ALK
- PTPRZ1-BRAF
- PTPRZ1-contactin
- PTPRZ1-c-Src
- PTPRZ1-ErbB4
- PTPRZ1-ETV1
- PTPRZ1-F3
- PTPRZ1-FGF2
- PTPRZ1-Fyn
- PTPRZ1-GIT1/Cat-1
- PTPRZ1-IL34
- PTPRZ1-MET
- PTPRZ1-MK
- PTPRZ1-N-CAM
- PTPRZ1-NFAM1
- PTPRZ1-NFκΒ
- PTPRZ1-Ng-CAM
- PTPRZ1-NYAP2
- PTPRZ1-p190 Rho GAP
- PTPRZ1-paxillin
- PTPRZ1-PI3K
- PTPRZ1-PTN
- PTPRZ1-TrkA
- PTPRZ1-TrkB
- PTPRZ1-VacA
- PTPRZ1-VEGFA
- PTPRZ1-voltage-gated sodium channels
- PTPRZ1-α4β1
- PTPRZ1-α6β1
- PTPRZ1-ανβ3
- PTPRZ1-β3 integrin
- PTPRZ1-β-adducin
- Rb
- RB1
- RB-E2F
- Retinoblastoma protein (Rb)
- RGD-fiber
- RIP2
- ROS
- S-100
- S100
- S100A4
- S100A8
- S100A9
- S100B
- S-100 protein
- SALL4
- Serpin E1
- SHH
- SLC17A7
- SLC18A2
- SLC1A5
- SLC6A1
- SNAI2
- Snail
- SOCS3
- Somatostatin receptors (SSTR)
- Sonic Hedgehog pathway
- Sox2
- SOX-2
- SOX2
- Spermidine/spermine N1-acetyltransferase 1 (SAT1)
- SPINT2/HAI-2
- SPP1
- Sry-related HMG-box factors
- STAG2
- STAT3
- STING
- STXVP2
- SUZ12
- Synaptophysin
- System A Amino Acid Transport PET Imaging with C-11-MeAIB
- TACC3
- Tau
- TCF3
- TEK
- Temozolomide (TMZ)
- TEMs
- TERT
- TERTp
- TERT promoter
- TERT promoter mutation
- TERT promoter mutations
- TERT (Telomerase reverse transcriptase)
- TERT (Telomerase Reverse Transcriptase)
- TGF-beta
- TGF-β
- Thrombospondin-3 (TSP3)
- Thyroid transcription factor 1 (TTF1)
- TIE2
- TIE2-expressing macrophages
- TIE2-expressing monocytes
- TIGIT
- TIM-3
- TIMP1
- TIMP metallopeptidase inhibitor 1 (TIMP1)
- TNC
- TNC (Tenascin-C)
- TNF
- TP53
- TP53 and PTEN mutations
- TrkA-B
- Tryptase
- Tryptophanyl-tRNA synthetase (WARS)
- TSPO
- Tumor protein 53 (p53)
- Twist
- TYRO3
- TYROBP
- UBE2S
- UBXN1
- Vasoactive intestinal peptide (VIP) receptors
- VEGF
- VEGF-A
- VEGFA
- VEGFR
- VEGFR1
- VEGFR2
- VEGF/VEGFR pathway
- VIM
- Vimentin
- VISTA
- Wnt
- WNT/β-catenin
- XIST
- YAP-Hippo axis
- Y-box Binding Protein-1 (YB-1)
- YHWA/14-3-3 family
- ZEB1
- αvβ3 integrin
- β-catenin
- Δ24-E1A
- ΔE1A
